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Resumo 
 A Nanomedicina está-se a tornar numa realidade cada vez mais sólida, graças 
aos avanços realizados na nanotecnologia, com a criação de soluções e terapias 
inovadoras para a cura de doenças crónicas. Sabe-se que a “protein corona” forma-se 
quando uma nanopartícula (NP) entra em contacto com meio biológico e esta 
presença vai afetar como a NP será “vista” por uma célula. Nesta tese, estudou-se o 
papel de proteínas adsorvidas na internalização de NPs de polistireno. Como seria de 
esperar, o perfil de internalização das NPs depende do tamanho das mesmas, das 
proteínas presentes à sua superfície e do tipo de células em estudo. A informação 
apresentada neste trabalho apoiou a complexidade da influência que a endocitose 
celular sofre, quando o tamanho das partículas ou as proteínas de soro são alteradas. 
De forma generalizada, descobriu-se que partículas mais pequenas que apresentam 
uma corona derivada de ‘proprietary blood fraction’ (PBF) sofrem uma menor 
internalização, quando comparadas com partículas de mesmo tamanho em meio sem 
soro; enquanto nanopartículas de maiores dimensões, apresentam maior 
internalização, quando comparadas com partículas do mesmo tamanho, nas mesmas 
condições. Esta tendência verificou-se em todas as linhas celulares, exceto nas linhas 
de MKN28 (CD44v6 + e CD44v6 -), onde as NPs de maiores dimensões que possuem 
uma ‘corona’ derivada do PBF possuem uma internalização semelhante às NPs de 
tamanho equivalente, incubadas em meio sem soro. Assim, os dados aqui 
apresentados confirmam a complexidade da endocitose de NPs, quando se altera o 
tamanho das NPs ou as proteínas do soro. A compreensão do motivo que leva a esta 
inversão na internalização, poderá levar a um melhor entendimento da endocitose e a 
possíveis novas técnicas de entrega de fármacos, em nanomedicina. 
 
Palavras-chave 
Nanopartículas, polistireno, nanomedicina, nanotecnologia, ‘protein corona’, proteínas 
de soro, endocitose. 
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Abstract 
Nanomedicine is becoming a more important and solid reality, thanks to the 
advancements made in Nanotechnology, with the creation of innovative solutions and 
therapies for currently untreatable maladies. It is well known that a protein corona is 
formed when a nanoparticle (NP) is dispersed in a biological medium and its presence 
will affect how the NP interacts with the cell. In this thesis, the role of adsorbed proteins 
in the internalization of NPs was studied by incubating polystyrene NPs, with varied 
sizes, in different types of serum and then the interaction of the previously incubated 
NPs with different cells types, was assessed. Results showed that the uptake profile of 
NPs was dependent of the NPs size, the proteins absorbed to their surface, and the 
type of cells studied. In general terms, results obtained allow to conclude that smaller 
NPs exhibiting a Proprietary Blood Fraction (PBF)-originated protein corona resulted in 
lower cell uptake, when compared to equally-sized NPs in serum free medium, while 
larger NPs presenting the same PBF-originated protein corona resulted in higher 
uptake, when compared to same-sized NPs in serum free medium. This tendency was 
verified among all used cell lines, except in the MKN28 (CD44v6 + and CD44v6 -) cell 
line, where the larger NPs presenting the PBF-originated corona had the same cellular 
uptake as same-sized NPs in serum free medium. Overall, the data presented here 
confirms the complexity of NP endocytosis, when size or serum proteins are changed. 
Understanding the reason for this change in the uptake could lead to a better 
understanding on the mechanistic of endocytose and, consequently, to possibly new 
drug delivery techniques in nanomedicine. 
 
 
Keywords  
Nanoparticles, polystyrene, nanomedicine, nanotechnology, protein corona, serum 
proteins, endocytosis. 
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1. Introduction 
 
1.1. Nanotechnology, Nanomedicine, Nanocarriers and 
Nanoparticles 
In recent years, nanotechnology has grown to become a solid concept that 
spread throughout the world and impacted all sectors of industry, from Bioengineering 
and Cosmetics to Energy and Medicine.1, 2 This term can be defined as the fabrication 
of new materials and systems with nanoscale dimensions between 1 and 100 nm.3 In 
the metric scale, a nanometer is one-billionth of a meter. As a comparative example, 
the diameter of a ribosome is 20-30 nm and the radius of the DNA structure 1 nm. 
Nanomedicine is the use of nanotechnology to develop new approaches, 
improvements and new therapies in healthcare.1, 4 New approaches include polymer 
therapeutics, like polymer-drug conjugates, polymeric drugs or block copolymer 
micelles.5 The interest of using polymers in drug delivery and gene therapy relies in 
their potential of functionalization, its macromolecular synthesis methods, and polymer 
diversity.5 All this allows a more direct therapy that focus, at the molecular level, on the 
unhealthy cells, instead of the healthy ones.  
Among the different polymeric structures available, the most studied strategy in 
nanomedicine is still based in the use of nanoparticles. In a broader sense, 
nanoparticles can be divided as nanospheres and nanocapsules, both implying distinct 
preparation methods. While nanospheres consist a polymeric system in which the drug 
is dispersed in the bulk polymer, nanocapsules are vesicular systems in which the drug 
is confined to an aqueous or oily cavity surrounded by a polymeric membrane.6  
Albanese et al. revised and discussed the evolution of NPs.7 The first 
generation of NPs addressed biocompatibility and toxicity of nanomaterials through 
material design, especially when dealing with nonbiodegradable particles (like 
polystyrene, polyacrylamide, and polyacrylate particles).8 These systems were 
designed in such a way as to ensure that particles exhibited rapid and efficient 
clearance, to avoid accumulation and tissue distribution at toxic levels.9 The second 
generation of NPs focused at optimizing surface chemistry, taking into consideration 
stability, stealth, and targeting capabilities of the NPs. The third and current generation 
of NPs embraced the idea of dynamic ‘smart nanomedicine’ with environmentally-
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responsive systems or even prodrugs to improve targeting mechanisms and 
theranostics abilities, i.e., the combination of therapy and diagnosis. 
It is currently widely accepted that for a nanocarrier to be successful, it must 
satisfy a number of design criteria, such as drug loading capacity, triggered or 
appropriate release, optimized biocirculation (stealth), serum/plasma stability, lack of 
toxicity, targeting ability, lack of immunogenicity, adequate cell uptake and be 
noncumulative.10 Although several combinations of nanoparticulate formulations have 
been developed, in the specific case of cancer the perfect nanocarrier platform capable 
of targeting a large range of cancer cells, with minimum side effects, is still out of 
reach, but much closer than it was several years ago, with several new approaches 
undergoing  clinical trials.11, 12 
 
1.2. Nanomedicine in Cancer 
Neoplastic cells are peculiar abnormal cells with several accumulated genetic 
mutations in key genes, which altered their behavior and morphology, leading to 
uncontrollable cell proliferation and an absence of cell death, and eventually to the 
formation of a tumor and progressing into cancer, afterwards. Hanahan and Weinberg 
proposed six hallmarks that constitute an organizing principle and helps understand the 
incredible diversity of neoplastic diseases. The following capabilities characterize most 
cancers: the ability to evade apoptosis; an acquired insensitivity to anti-growth 
suppressors; a sustained proliferation signal; the activation of invasion and metastasis; 
the limitless replicative potential; and the ability to sustain angiogenesis.13 The 
acquisition of these capabilities is possible due to the cell’s genome instability and 
mutations in genes that regulate the above mentioned abilities and a tumor-promoting 
inflammation, which aids in the creation of an adequate microenvironment for tumor-
proliferation.14 They also suggested two additional new hallmarks, probably involved in 
the pathogenesis of some or even all cancers: the capacity to reprogram cellular 
metabolism in order to effectively support neoplastic proliferation; and the ability to 
evade the immune system’s agents.14 Such diversity, combined with its potential to 
develop resistance to current therapies, is what makes so difficult to treat it.15 
Understandably, cancer is the second worldwide cause of death, exceeded only by 
cardiovascular diseases.16   
The selection of an anti-cancer therapy depends on the type of cancer, its 
location and grade diagnosed. Well localized solid tumors are normally treated with 
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surgery, and mostly complemented with chemotherapy and/or radiotherapy. Such 
treatments also have a negative impact on healthy cells, causing their death. To 
overcome those relevant drawbacks, and especially the side-effects on healthy cells, 
new and more targeted approaches have been developed and several targeted 
treatments are already clinically available, involving antibodies or drugs, used to treat 
specific types of cancer, such as for example: Trastuzumab (HER-2 positive metastatic 
breast cancer), Rituximab (diffuse large B cell non-Hodgekin’s lymphoma), or Geftinib 
(non-small cell lung cancer), among others approved by the FDA and EMA.17 
Nanomedicine has also been contributing with new drug delivery systems, 
providing promising anti-cancer therapies and/or improving chemotherapy. 
Nanocarriers are claimed to be able to accumulate preferably in tumors, avoiding 
healthy tissues, achieving cytotoxic concentration several-fold higher, and with reduced 
toxicity for the rest of the body, compared with free drugs.18-20 The nanocarrier also 
protects the agent from degradation, reduces renal clearance and increases its half-life 
in the bloodstream, allowing for a smaller dosage of the drug to be used.20 Additionally, 
the defective vasculature surrounding the tumors also allows passive accumulation of 
nanocarriers in tumor tissues, releasing the chemotherapeutic agents in its vicinity – 
the so called enhanced permeability and retention (EPR) effect.21 
Current anti-cancer therapies in the clinics which use nanoparticulate systems 
include some of the following drugs: Taxol®, micelles containing paclitaxel which are 
used as part of first-line chemotherapy (approved on 1992, FDA); Oncaspar®, a 
polymer-protein conjugate used on acute lymphoblastic leukemia (1994, FDA and 
2014, EMA); and Abraxane®, albumin nanoparticles bound with paclitaxel used on 
metastatic adenocarcinomas of pancreas and metastatic breast cancer, among other 
types of cancer (2005, FDA and 2008, EMA). Several other promising new therapies 
are also under clinical evaluation.11  
In summary, the current major focus in this area is focused on developing 
improved ways to specify the targets of drug delivery carriers, so that these are only 
internalized by the target cells. However, the whole field still requires a deeper and 
better understanding on the mechanisms of endocytosis to improve its efficacy.22 
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1.3. Nanoparticles and Cellular Uptake 
Beyond this point, the different endocytic mechanisms, the NP physicochemical 
properties and their effects on the uptake will be discussed, followed by an introduction 
about the protein corona. 
 
1.3.1. Endocytic Mechanisms 
Here, some aspects and considerations of the unique and different uptake 
pathways are summarized.  
Phagocytosis is a well characterized pathway, unique to specialized mammalian 
cells such as neutrophils, monocytes and macrophages. These cells are part of the 
immune system whose role is to internalize and digest cellular debris and pathogens, 
being one of the most important physiological line of our organism’s defense. When a 
pathogen is recognized by specific cell surface receptors signaling cascades, mediated 
by Rho-family GTPases, are induced and trigger polymerization of actin membrane 
protrusions at the ingestion site.23 
Clathrin-mediated endocytosis (CME) involves specific receptors that recognize 
and internalize cargo into “coated pits”, constituted by an assembly of cytosolic 
proteins, clathrin, which is the main assembly unit. These coated pits invaginate and 
close off to form early endosomes, which will later fuse with lysosomes.24-26 Typical 
sizes of coated pits range from 60-200 nm diameter.27 
Caveolae-mediated endocytosis happens as the result of the clustering of lipid 
raft components and the interaction of different proteins, especially caveolin, with the 
cellular membrane. The final product is the caveolae, flask-shaped invaginations, which 
are very abundant at the surface of endothelial cells. Internalization via this pathway is 
induced by specific ligands, such as simian virus-40 or cholera toxin. It is also 
considered to be the predominant pathway of entry for particles bigger than 200 nm.27-
29 
Other internalization pathways have been classified as clathrin- and caveolae-
independent endocytosis, which involve other types of cholesterol-rich microdomains 
on the plasma membrane. These domains, capable of diffusing on the cell surface, are 
generally known as lipid rafts and have a diameter of 40-50 nm, and are capable of 
internalizing particles with ~90 nm in diameter.30-33 
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Lastly, micropinocytosis involves the internalization of big areas of the plasma 
membrane, together with large amounts of fluid. Since uncoated vesicles can be bigger 
than coated ones, this endocytic pathway allows the uptake of larger objects (>150 
nm). Actin rearrangement, together with the stimulation of Rho-family GTPases, are a 
crucial part of this mechanism.34, 35 
 
Figure 1- Multiple endocytic portals that allow entrance into the cell (adapted from Conner et al).32 
 
 
1.3.2. Influence of Particle Size, Shape and Surface 
Chemistry 
Particle size can be controlled through multiple material selection parameters 
(e. g., surfactant used, polymer type, and concentrations) and through various 
fabrication methods (e. g., type, nozzle diameter, flow rate, control agent, monomer, 
initiator, polymerization, and emulsion type.12, 36, 37 Nanoparticle size affects both the 
uptake efficiency and kinetics, the internalization mechanism, the subcellular 
distribution, the functions of circulation, targeting (interaction with the cells), 
degradation, toxicity and opsonization. According to some works, the nanoparticle size 
will even influence some of the corona’s characteristics, like thickness, composition 
and protein activity, which will modulate their cellular interactions. 37-42  
The route of NP uptake, which can be affected by the cell membrane-
nanoparticle interaction, may be defined by two successive stages: the adhesion 
process of the particle to the cell membrane and an internalization process.43 A size-
dependent uptake has been observed in different cell lines, independently of the 
particle material composition.7, 38, 40, 43-48  Hoekstra et al. used a range of fluorescent 
latex beads of defined sizes (50-1000 nm) to investigate the effect of NP size in non-
phagocytic B16 cells and verified that the internalization of NPs <200 nm was observed 
to involve Clathrin-coated pits. But when the size was increased, caveolae-mediated 
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internalization became more apparent and predominant, especially in the entry route 
for 500 nm particles.27 Rafailovich et al. reported that 45 nm Au NPs entered cells via 
clathrin-mediated endocytosis, while the smaller 13 nm particles went mostly through 
phagocytosis.49 Chan and coworkers studied the uptake of Au NPs (14-100 nm) in 
HeLa cells and reported maximum uptake for 50 nm particle.50 Kulkarni et al. studied 
the uptake of PS NPs (size range 25-500 nm) for drug delivery across the blood-brain 
barrier. NPs with diameters <200 nm were taken up by Caco-2, a human colon 
adenocarcinoma cell line, and MDCK, Madin-Derbey canine kidney cells. The 100 nm 
particles resulted in maximum uptake, in Caco-2 and MDCK cell lines, while the 500 
nm were poorly internalized. Smaller NPs were cleared by the reticuloendothelial 
system (RES), which reduces the uptake efficiency due to the reduced circulation time 
(<100 nm). In addition, smaller NPs do not have a small enough surface area to meet 
the energy requirements for the membrane bending process, which occurs before 
endocytosis. It is suggested that 100-200 nm particles are internalized by receptor-
mediated endocytosis while larger particles, are taken up through phagocytosis.46 
Nanoparticles with a diameter <100 nm are able to penetrate into tumors, through its 
leaky vasculature (EPR effect). But within the tumor microenvironment, the EPR effect 
is mitigated most of the times due to the presence of host stromal cells, which contain 
cancer-associated fibroblasts that can promote cancer initiation, angiogenesis and 
metastases.51 
Overall, when comparing several works, it can be noticed that there is usually 
an optimal size for an efficient uptake of NPs and this critical size will vary depending 
on the cell type used and surface properties of the NPs. It seems also evident that, due 
to the great variation found in the literature regarding “ideal” nanoparticle size, it is 
challenging to correlate beyond any doubt a particular cellular response with NP size.38 
Several studies have presented contrasting results based on the cell line under study, 
NP material and its surface properties, differing polydispersity values, probe area 
complexity, among other more specific parameters.52 In what concerns particle size 
and its influence on cell uptake the real challenge seems to lies in working through the 
combinations of potential nano-bio situations and to try and understand how and why 
certain outcomes are obtained. Guidelines for what particle size might be useful for 
certain applications in nanomedicine are listed in the following Table 1. 
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Table 1- Nanoparticle size relative to clearance and applications. 
Particle Size (based 
on Rigid Sphere) 
Nanomedicine Applications Ref 
< 10 nm Fast clearance through extravasation or through urinary system. 53 
10-20 nm Detection, imaging, potential to cross blood-brain barrier (BBB). 54 
20-100 nm 
Drug/gene delivery, cancer therapy, sites of inflammation (optimal 
range to avoid physiological barriers; high circulation potential, 
reduced hepatic/splenic filtration). 
53-56 
100-200 nm Drug/gene delivery (high potential for prolonged circulation) 54 
200 nm-1 μm Generally cleared by the spleen. 56 
>1 μm 
Normally opsonized and accumulate in liver and spleen, being 
cleared from circulation almost immediately. 
53, 54 
 
A particle’s shape also influences the adhesion and transport of particles.47 It 
can also influence the efficiency of cellular uptake. Nanoparticles of the most various 
shapes and forms have been made and reported, from nanorods to nanostars, and 
from filomicelles to nano-bullets.57 
Spherical nanoparticulate systems are the most commonly studied 
nanoparticles, both in vivo and in vitro, due to several advantages that can be grouped 
in the following four areas: a versatile and modifiable platform to build upon, a high 
surface-to-volume ratio, shape and size, and unique optical properties.58 Also, 
nanocarriers have been mostly designed as spheres simply because of the ease of 
manufacture, restricting information on the influence of nanoparticle shape on 
biocirculation.59, 60  
Assymetrical and nonspherical polymeric nanoarchitectures have been 
considered in nanomedicine as a way to perform complex tasks and mimic complex 
biological systems. 61-63 The usage of differently shaped-particles allows unique 
interactions with complicated biological systems in adhesion, transport, drug 
delivery/release, circulation time, and biodistribution.64 Nanomedicine applications, 
such as sensing, self-assembling, tissue engineering, immunoengineering, and 
therapeutic and diagnostic delivery will benefit from the existence of these 
nanoparticles. 12, 65  
In a mini-review, Tao et al. described several top-down engineering methods to 
produce nanoparticles with a certain shape: particle replication in nonwetting template 
(PRINT®) methods, stretching of polystyrene particles, step flash imprint lithography 
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polyethylene glycol diacrylate (S-FIL PEGDA) particles, and template-induced printing 
of nanoparticles.66  Different shaped nanoparticles, other than spheres, include: 
rectangular disks, rods, worms, oblate elipses, elliptical disks, needles, plateloids and 
circular disks, to name a few.12, 66 Such unique morphologies, with complex surfaces, 
could allow a more controlled targeted delivery based on the potential for variable 
ligand presentation that could originate. However, the surface-cell interactions will be 
more difficult to understand, considering the resulting nano-biointerface and the 
different presentations a particle could be introduced to a cell upon uptake.12, 66 For 
example, a rod-shaped particle can be presented on its short axis (or rocket mode) or 
long axis (submarine mode), which can lead to two very different cellular responses.12, 
67 
 Gratton et al. fabricated micrometer-sized particles in various shapes with the 
PRINT® technique. The research focused on whether the particle morphology affected 
cellular internalization and intracellular trafficking by HeLa cells. It was found that rod-
like particles with a high aspect ratio had increased internalization rates, almost four 
times faster than more symmetric cylindrical low-aspect-ratio particles.68 
Discher et al. reported the persistent circulation of soft filamentous or worm-like 
micelles of approximately 1 week in mice and rats, proving the importance of 
nanoparticle shape.69 The circulation time of filomicelles in the human body was 
estimated to be up to 1 month.69, 70 Polymeric fillomicelles have nanoscale diameters 
ranging from 22-60 nm tuned by the polymer molecular weight and with contour length 
controlled by repeated extrusion of worms through nanoporous filters.71 The filomicelles 
were constituted by a hydrophilic PEG corona and a hydrophobic core of inert 
polythethylene or biodegradable polycaprolactone. Unlike filomicelles, PEGylated 
spherical stealth vesicles (presenting the same surface characteristics as the 
filomicelles) injected at the same dose were cleared within 2 days, firmly establishing a 
correlation between the nanoparticle shape and circulation time.10 Furthermore, 
filomicelles with a contour length of  approximately 8 μm had the longest circulation 
time, while longer particles quickly fragmented, following injection in mice, indicating a 
relation between filomicelles contour length and circulation time.69  
Concerning other cylindrical shapes, PEGylated gold nanorods were observed 
to have reduced clearance, with longer circulation times when comparing to their 
spherical counterparts.72 Zhou et al. reported similar results using nanorods with a 
hydrophobic biodegradable camptothecin core and a hydrophilic coat constituted by 
linear PEG and dendritic polylysine. These rods were found to have prolonged 
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circulation times, high cellular uptake and increased accumulation in mice tumors 
compared with the spherical nanoparticles.73 
Other unusual shaped-nanoparticles include Janus particles, “dumbbells”, 
“snowmen”, “rattles”, “raspberries”, “stars”, “flowers” or even “sea urchins”. These 
surprising nanoparticles have peculiar shapes which affects their biological activity and 
the cellular and their in vivo fate.38, 74  
Janus nanoparticles are asymmetric spheres with two physically or chemically 
distinct surfaces. Janus nanoparticles are named after the roman god Janus whose 
head is represented with two opposite faces. Several combinations of multicomponent 
hetero-nanostructures have been made, including either purely organic or inorganic 
particles, as well as composite organic-inorganic compounds. As such, they have 
attracted increased interest in the area of biomedical applications, especially for 
theranostics and treatments.75 A number of published articles focus on the preparations 
of such particles.76-79 For instance, Shao et al. engineered multifunctional Janus 
nanocomposites, constituted by a metallic head of magnetic Fe3O4 and a body of 
mesoporous SiO2 containing DOX (doxorubicin). These “nano-bullets” (M-MSNs-DOX) 
possessed superior magnetic properties, a finer controlled aspect-ratio and defined 
abundance in pore structures. M-MSN-DOX was tested on subcutaneous and 
orthotropic liver tumor models in mice, it was reported that the proposed Janus nano-
bullets, when under the influence of a magnetic field, had an increased endocytosis by 
cancer cells and were able to suppress tumor growth and significantly reduced 
systematic toxicity, since pH-promoted DOX release only happens in the acidic 
environment found in these cells.   This study is an example of an intriguing targeting 
strategy for safe and efficient liver cancer treatment based on a novel bullet-shaped 
Janus NP.80 
Considering all published literature, it seems clear that the factors discussed 
previously have a determining influence in a nanoparticle’s behavior in vivo and in vitro 
(especially in cellular uptake). However, the current conflictive nature of the evidence 
obtained make it premature to draw detailed and absolute conclusions on the effect of 
the several parameters, namely concerning particle shape. Further work needs be 
dedicated to investigating the effects of size, shape, charge, surface characteristics, 
rigidity, protein corona composition, nanoparticle concentration, as well as cell types, 
endocytosis mechanisms, medium, flow velocity, and others factors. A better 
understanding on how each parameter independently affects cellular uptake and 
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nanoparticle behavior, and, at the same time, the complexity of their interplay is 
required. 
In the context of the present work, it is also reasonable to consider that the 
corona will also be influenced by the size of the nanoparticles. According to Cedervall’s 
results, there was a distinct difference in the degree of protein surface coverage of the 
NPs depending on their size, with a larger degree of protein coverage on the larger 
particles. When decreasing the NP size, from 200 to 70 nm, a suppression of the 
protein adsorption was observed.81 Such suppression could be due to the NP’s 
curvature. Klein claimed that the curvature of smaller NPs suppressed the adsorption 
of certain proteins, mainly those with larger size or less conformationally flexible 
proteins.82 Despite all the advantages of using NPs for therapeutic purposes, namely 
for smart therapeutics or personalized medicine, there is still a small number of FDA or 
EMA-approved NP-based treatments, drugs and devices.12 A better understanding of 
the influence protein corona on the cellular uptake of nanoparticles, and its modulation 
through different types of serum, may eventually contribute for new achievements in 
nanomedicine. 
 
1.3.3. Protein Corona 
An important aspect to take into consideration when considering the use of 
nanoparticles is their fate after entering the human body. Nanoparticles, due to their 
size, are processed and taken into the cell by active, energy-dependent processes. 
The primary contact between both is mediated by the nanoparticle’s surface in the 
biological medium.27, 68, 83-85 But when the surface of nanoparticles comes in contact 
with any biological medium or body fluid, it will be modified by the adsorption of 
biomolecules such as proteins and lipids, culminating in the formation of a layer of 
molecules called “protein corona”.40, 81, 86-89 The primary forces for adsorption of 
proteins on nanoparticles are hydrophobic and electrostatic, so the surface charge will 
also affect the resulting corona.90, 91 
The “protein corona” has a dynamic nature since a limited number and specific 
type of biomolecules will compete for the nanoparticle’s surface, resulting in a corona 
containing a few (mostly) identifiable proteins.81, 86, 92-96 If the exchange kinetics is slow 
enough (depending on the coating proteins and the experimental setup), the corona will 
be biologically relevant and it will be the primary contact with the cells, becoming the 
nanoparticle’s biological identity.81, 97, 98 In other words, the identity, organization and 
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lifetime of these proteins adsorbed on the particle’s surface affects the way cells will 
interact with, recognize and process these nanoparticles.87, 94  
Dawson and Lynch hypothesized that once the nanoparticle is dispersed in any 
biological fluid, a cell will only “see” the system in which the core nanoparticle is 
surrounded by a “hard” corona of slowly exchanging proteins, tightly bound, and an 
outer layer of weakly interacting protein-protein complexes, rapidly exchanging with the 
proteins present in the environment (“soft” corona).99-102 Milani et al. confirmed this 
theory through their study of reversible vs. irreversible binding of transferrin to 
polystyrene nanoparticles.103 Between the two, the inner hard corona is of high 
scientific relevance and also the most studied.99, 103 
The biological media can contain thousands of biomolecules. The blood plasma 
alone has almost 3 700 identified proteins, thus allowing the formation of different 
combinations and organizations of coronas on nanoparticles.97, 104 Despite the huge 
numbers of identified proteins, only a few dozens of proteins form the hard corona, 
since their affinity to the NP bare surface is very high, even if their current abundance 
in the biological fluid is low.105-112 
According to Lundqvist’s work, the proteins identified in the surface of 
nanoparticles incubated in human plasma can be organized in six main groups: 
immunoglobulins, apolipoproteins, which are responsible for the transport of lipids and 
cholesterol in the bloodstream, proteins from the complement pathways, a very crucial 
system in the innate immunity, and acute-phase proteins, also part of the immune 
system and that share some of its proteins with the complement pathways. The last 
two groups include coagulation factors, like fibrinogen or factor V, and other proteins 
like clusterin, serum albumin and vitronectin.92 
Such variety could indicate that each nanoparticle would have a unique 
biological identity. But, even though the composition of the different particle-protein 
organizations in biological media may vary, if well-designed dispersion protocols are 
used throughout the experiments, one will achieve a high level of reproducibility of the 
populations of different particle-protein organizations, allowing a rational and 
reproducible approach to the study of bionanoparticle interactions with living 
organisms.99 
As previously mentioned, the interaction between a cell and a nanoparticle will 
be mediated through the “protein corona”. For a given nanoparticle, only several dozen 
proteins bind in significant amounts and for long enough to be biologically significant 
and recognized by the cell.97 The recognition can either be generic or highly specific, 
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involving receptor-ligand interactions and leading to the binding of the nanoparticle to 
the cell, mediated by the corona. Such event will lead to its internalization, with a 
previous possible reorganization of the cell’s membrane.113, 114   
The interaction between both sides will only be possible if the protein corona 
has a slower exchange with other proteins present in the medium, compared with the 
time it takes for the particle to attach to the cell surface. This way, the corona (very 
likely the “hard” corona) will affect and mediate the nanoparticle-cell interaction.104 But 
it is also possible that the proteins are not recognized by any membrane receptor 
(these are called bystander proteins in such situations) or they may be bound to the 
particle without presenting any relevant receptor-binding sequence. Compared to 
these, bare nanoparticles have a greater non-specific affinity to the cell surface and 
consequent internalization.104 As a consequence, the cellular uptake of the 
nanoparticle-protein complex depends also on the presence of membrane receptors for 
the proteins present in the corona, and as along as the proteins are presented in the 
correct orientation favoring the interaction with the receptor, and as along as the 
nanoparticle-bound protein can compete effectively with the free proteins for the 
receptor.104 
 Although the extremely relevant effect of the protein corona in nanoparticle cell 
uptake is already widely accepted very little is still known about the effects of the 
corona and the proteins involved mainly due to its complexity and influencing 
parameters.115 The adsorption may also cause conformational changes in the proteins 
structure116, changes in membrane activity, transport processes, aggregation, avidity, 
and cell signaling.7, 87, 117 In a way, with new alterations happening at the protein 
corona, a new biomaterial will be presented to the cells based on the combined effects 
of the NPs’ physicochemical properties and the altered biological functions of the 
adsorbed proteins.116 Consequently, what will happen when a NP approaches a cell, if 
the proteins at the corona will have their conformations altered, if the membrane itself 
will be changed, or if any other phenomena may happen, are still essentially 
unanswered questions.12 
With the corona itself being modulated by the physicochemical properties of the 
nanoparticles, the resulting combination will dictate the NPs’ pharmacokinetics and 
pharmacodynamics, the cell’s uptake efficiency, the internalization pathway selection, 
the intracellular location, and cytotoxicity. 22, 45, 66 But these parameters are not totally 
dependent on the nanoparticle and its corona, but are also dependent on cell-specific 
characteristics such as cell type or cell cycle phase.118 
FCUP/ICBAS 
The role of adsorbed proteins in the internalization of polymeric nanoparticles 
13 
 
Cell-type specific variation in the processing of NPs can be expected, since 
even in closely related cell lines, significant differences in intracellular sorting, 
trafficking and localization of non-conjugated quantum dots (QDs) were reported (three 
lines of human prostate cancer cells).119 Also, the polyvalent surface of NPs may 
induce cross-linking of cellular receptors, starting signaling processes, initiating 
structural alterations at the cell surface, and interfere with normal cell function.85, 120 
Another aspect to consider, when studying cellular uptake of nanoparticles, is that the 
rate of endocytosis may also depend on the cell density.121, 122 
In order to contribute to answer some of these questions the present work is 
aimed at evaluating how nanoparticles size and the protein corona affect nanoparticle 
internalization in a broad range of cell lines. Different sera will be used, most likely 
giving rise to distinct protein coronas, which will in turn be influenced by the size of the 
nanoparticle. Understanding, and eventually manipulating, the interplay between 
nanoparticles characteristics, protein corona formed and the endocytosis mechanism 
for a specific target cell population (like tumor cells), may constitute a major step 
towards more efficient nanomedicines.  
 
 
2. Aim 
The purpose of this thesis is to study the role that adsorbed proteins in the 
cellular internalization of nanoparticles (NPs), as a function of NP size, type of serum 
used and cell type.  
 
 
 
  
FCUP/ICBAS 
The role of adsorbed proteins in the internalization of polymeric nanoparticles 
14 
 
3. Materials and Methods 
 
3.1. Materials 
Red dye-loaded (excitation/emission wavelengths – 580/605 nm) fluorescent 
carboxyl-modified polystyrene NPs (Fluospheres® size kit, ThermoFisher®) were used 
without any modification or purification. Sizes used in this work were 20, 40, 100, 200 
and 500 nm. All stock solutions were stored at 4ºC, and used within 1 year of 
purchase, in order to ensure their stability. 
 
Figure 2 - Respective fluorescence intensity value of each different sized-nanoparticle. As it can be seen, the particles 
with nominal size of 500 nm possess the biggest fluorescence intensity, among the range of used NPs. 
 
Human embryonic kidney Hek293t cells (passage 10-15), Human cervix 
epithelium Hela cells (passage 3-10), human stomach adenocarcinoma cells MKN28 
(passage 30-50), human stomach adenocarcinoma cells MKN28 (CD44 variant domain 
6 positive (CD44v6 +), passage 5-9), human gastric adenocarcinoma AGS cells 
(passage 2-9), human diffuse gastric carcinoma cells GP202 (passage 10-16) and a 
human bone marrow derived mesenchymal stem cells (hMSC, passage 2-9) were 
used. All cell lines were available from the i3S/INEB BioBank, except both MKN28 cell 
lines, which were supplied by Carla Oliveira (Expression Regulation in Cancer, i3S). 
A broad range of cell lines was used to understand how the NPs internalization 
plays out on several tissues and organs. With the exception of Hek293t and hMSC, 
most of these are cancer cell lines, stomach derived, due to the work and interest the 
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group has in this area.123, 124 Furthermore, two similar cell lines, MKN28 expressing or 
not CD44v6 were also used. CD44 is a known cell-surface glycoprotein involved in cell-
cell interactions, cell adhesion, and migration.125 Certain CD44 variant isoforms, 
especially those containing CD44v6 have been implicated in oncogenesis, tumor cell 
invasion and metastasis, primarily associated with epithelial derived tumors. In 
nonmalignant tissues, CD44v6 expression is essentially restricted to a subset of 
epithelia.126-129 Being two similar cell lines, their use here was destined to check if the 
presence/absence of CD44v6 altered the NP uptake of the cell. Since CD44 is a 
glycoprotein involved in cellular interaction and adhesion, the possibility of it having 
significant changes in the NP uptake between the two cell lines was presumed, 
although this possibility was expectedly low. 
Two cell culture media were used in this work: Roswell Park Memorial Institute 
Medium 1640, with [+]-L-glutamine (RPMI, Gibco©), and Dulbecco’s Modified Eagle’s 
Medium (DMEM, Gibco©). 
Different types of serum were used to allow the study of the influence of the 
protein corona formed on NPs, namely: fetal bovine serum (FBS, Biowest), “proprietary 
blood fraction” (PBF, Orthosera, Austria) and human albumin (HA, Biotest). Complete 
medium (CM) was the designation used to refer to medium supplemented with serum, 
while serum free medium (SFM) was medium without any serum, equivalent to a ‘no 
serum’ condition. 
The PBF serum, produced by Orthosera, is a specific, growth-factor rich human 
serum fraction, which has shown superior effects in promoting cell proliferation in 
osteoarthritic bone and cartilage cells.130 As part of a collaboration, we are studying the 
potential of this serum, on behalf of Orthosera. All samples of PBF were obtained from 
the same donor. 
FBS serum was chosen, since it’s also a rich type of serum. This way 
comparison between the results obtained in this condition, with the ‘PBF’ condition, is 
possible. While HA serum was chosen, since it was the simplest type of serum, 
containing only human albumin. It’s known that albumin is also present on FBS and 
PBF serums. 
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3.2. Cell Culture 
MKN28 (CD44v6 -), AGS, GP202, HeLa, Hek293t cells were cultured at 37ºC in 5% 
CO2 in RPMI Medium 1640 (Gibco©) supplemented with 10% fetal bovine serum (FBS, 
Biowest) and 1% penicillin/streptomycin (Biowest). 
hMSC cells were cultured at 37ºC in 5% CO2 in Dulbecco’s Modified Eagle’s 
Medium (Gibco©) supplemented with 10% FBS (HyClone, GE Healthcare Life 
Sciences©) and 1% penicillin/streptomycin. A different FBS was chosen, since there 
are certain differences between two FBS produced by different companies, and the 
hMSC cells grow faster in cDMEM, supplemented by FBS (HyClone). 
MKN28 (CD44v6 +) cells were cultured at 37ºC in 5% CO2 in RPMI Medium 1640 
(Gibco®) supplemented with 10% foetal bovine serum (FBS, Biowest) and 1% 
Geneticin® (G418) Sulfate (ThermoFisher©). 
All cell lines were confirmed to be mycoplasma negative through PCR analysis 
involving specifically designed primers to detect mycoplasma DNA. These tests were 
done monthly. 
 
3.3. Determination of Serum Protein Content 
Different serum percentages were used to ensure the same protein content in that 
each condition. To determine the protein content, the colorimetric BCA Protein Assay 
kit (ThermoFisher®) was used. The measurements were performed on a SynergyMx, 
BioTek®. The absorbance was read at 655 nm. 
After determining the protein content of each serum, the % equivalent of PBF and 
HA in CM was calculated in order to achieve the same protein content as 10% FBS, 
which corresponds to the usual % of serum added to cell culture medium to obtain CM. 
The following table contains the percentage of serum volumes that were required to 
ensure that, in the end, the same protein content was present is all conditions tested. 
Table 2 – Serum % range used in complete medium (CM) throughout the work whenever new aliquots were prepared 
and assayed with BCA Protein Assay kit. 
Serum Serum % added to SFM 
FBS 10 % 
PBF 10.7 – 11.4 % 
HA 16.4 – 20.5 %  
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Whenever a new aliquot of serum was needed, a new BCA protein assay was 
performed on all the sera used to ensure that all work conditions had the same protein 
content. 
  
3.4. Formation of Protein Corona on NPs 
NP dispersions were prepared by diluting the concentrated stock solutions in 
complete medium (DMEM or RPMI; supplemented with the different % of sera defined 
in item 2.3) or serum free medium (SFM) used for cell culture at room temperature, 
immediately prior to the experiments on cells, with an identical time delay between 
diluting and introducing NPs to the cells for all experiments. Before sampling, NPs were 
vigorously mixed by vortexing for 30s. After the addition of the NPs to the different 
incubation solutions, these were also vortexed for 15s to ensure maximum NPs 
dispersion. 
 
3.5. Characterization of Nanoparticles 
The mean size and surface charge of NPs were determined using a photon 
correlation spectrophotometer (Malvern Zetasizer Nano ZS). The mean size is related 
to the hydrodynamic diameter, measured through the Dynamic Light Scattering (DLS) 
technique, and surface charge is related with zeta potential, determined through laser 
Doppler Micro-eletrophoresis (DME). Measurements were performed at 25ºC in 
phosphate-buffered saline (PBS) solution and in RPMI, without serum or supplemented 
with the different sera with the appropriate %, to ensure same protein content, as 
determined in item 3.3.  
 
3.6. NPs Uptake by Cells 
40x103 or 20x103 (uniquely for hMSC) cells were seeded in 24-well plate (Falcon®) 
and incubated for 48h prior to the addition of NPs. Afterwards, cells were incubated 
with culture medium supplemented with the different sera under study and the 
differently-sized NPs for 24h. The final concentration of NPs used in the incubation 
solution was 20 µg/mL, a concentration used in past uptake experiments and one that 
didn’t present any signs of toxicity. Negative controls consisted in the several serum 
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conditions but without NPs. For time profiles experiments the incubation time was of 30 
min, 1, 3, 6 and 24h. 
After this incubation time, the medium was removed and the samples were washed 
thrice with PBS (1x), to ensure particle removal from the outer cell membrane. The 
fluorescence intensity of all PBS washes of the 24-well plates demonstrated the 
efficiency of the washes, following particle removal. Cells were then trypsinized for 5 
min at 37ºC. After cell detachment confirmation, CM was added to neutralize the 
trypsin and all the content transferred to polystyrene round-bottomed tubes (Falcon®), 
before samples were immediately analyzed by flow cytometry.  
 
3.7. Analysis of NPs internalization by Flow Cytometry 
NPs internalization was analyzed immediately after their incubation with cells 
using a fluorescent-activated cell sorter (FACS) Calibur (BD Biosciences©) flow 
cytometer. The results are reported as the mean of the distribution of cell fluorescence 
intensity obtained by measuring 2000-10 000 cells (depending on each cell line), 
averaged between 2 independent replicas of 3 independent experiments. Error bars 
correspond to the standard deviation between these 3 independent experiments. 
For the imaging cytometry analysis, the same protocol described previously for 
sample preparation of the flow cytometry, was used. Samples were analyzed on an 
imaging flow cytometer ImageStreamX© (Amnis, EDM Millipore), acquiring at most 10 
000 cells at the Bioimaging Center for Biomaterials and Regenerative Therapies 
(b.IMAGE, i3S). A 488 nm wavelength laser was used to excite NPs ﬂuorescence, 
which was collected using the 595–660 nm spectral detection channel (Ch04). Other 
instruments setting included the following: 488 nm laser power: 10.00; 785 nm laser 
power: 11.00; Cell Classifier: area upper limit Ch01 – 400, area lower limit Ch01 - 40. 
The analysis of multiple image-based parameters was performed using the IDEAS 
software (v6.2.64, Amnis Corporation, EDM Millipore). The Internalization feature was 
used to evaluate the obtained results. 
 
  
FCUP/ICBAS 
The role of adsorbed proteins in the internalization of polymeric nanoparticles 
19 
 
4. Results and Discussion 
 
4.1. Protein Quantification in Different Types of Serum 
In order to ensure that each condition (media supplemented with FBS, PBF or 
HA) had the same protein content, avoiding the excess/deficit, in terms of protein 
content, that could influence the results, the BCA protein quantification assay kit was 
used to determine total protein concentration in each serum type used. This kit was 
chosen due to its simple protocol, high linearity and fast reaction time. The kit is 
provided with standard albumin samples to be assayed and used to produce a 
calibration curve. The example provided in Table S2 and S3 demonstrates how it was 
used to determine the protein content. 
Using the equation from the calibration curve (Fig. S1), it was possible to 
determine the protein content in each serum type under study and thus determine the 
volume of each serum required and used in serum free medium (SFM) to keep the 
protein content constant in every condition tested.  
 
4.2. Influence of Serum Type on Protein Corona Formed 
Carboxylated-modified polystyrene NPs with nominal sizes of 20, 40, 100, 200, 
and 500 nm were selected as the model particles in order to understand the influence 
of size, combined with different protein corona, in their internalization by different cell 
lines. These NPs were chosen since they are widely available to the scientific 
community, have been extensively studied, present low toxicity and have already been 
used by the group in past uptake experiments.131-133 A large range of sizes was used to 
allow a more in depth characterization. 
The NPs characterization was done, using a zetasizer, to evaluate particle size, 
polydispersity, charge and relative permittivity of the different particle dispersions 
produced in this work. 
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Table 3 - Polystyrene NPs characterization after incubation in PBS buffer or in cell culture medium supplemented with 
the different sera in study (FBS, PBF and HA), or without serum (no serum). Results here are presented as mean ± 
S.D., averaged from three independent measurements, of one independent experiment. 
NP initial 
size (nm) 
Medium 
supplementation 
Size 
(nm) PDI 
Charge 
(mv) 
ε 
(μm.cm/v.s) 
20 
PBS 34.36 ± 0.67 0.217 ± 0.009 -31.93 ± 1.03 16.3 ± 0.4 
No Serum 60.68 ± 1.60 0.286 ± 0.040 -24.43 ± 1.51 15.1 ± 0.4 
FBS 72.69 ± 9.81 0.462 ± 0.219 -8.09 ± 0.81 15.8 ± 1.3 
PBF 59.57 ± 3.22 0.822 ± 0.034 -7.54 ± 0.83 14.3 ± 0.4 
HA 19.23 ± 0.86 0.757 ± 0.022 -8.17 ± 0.60 13.5 ± 1.0 
40 
PBS 50.78 ± 0.38 0.039 ± 0.016 -35.40 ± 1.18 17.0 ± 0.6 
No Serum 53.81 ± 0.71 0.035 ± 0.016 -21.86 ± 1.03 14.9 ± 0.7 
FBS 53.25 ± 0.29 0.514 ± 0.001 -9.71 ± 0.09 14.7 ± 0.5 
PBF 63.18 ± 2.50 0.833 ± 0.038 -9.55 ± 1.04 14.3 ± 0.4 
HA 44.94 ± 7.91 0.478 ± 0.080 -10.01 ± 0.60 12.7 ± 0.3 
100 
PBS 109.27 ± 1.25 0.012 ± 0.011 -39.07 ± 1.37 16.8 ± 0.5 
No Serum 117.20 ± 7.62 0.107 ± 0.003 -23.50 ± 1.39 15.2 ± 0.6 
FBS 160.07 ± 5.26 0.285 ± 0.001 -9.27 ± 0.49 15.2 ± 1.0 
PBF 104.85 ± 10.52 0.482 ± 0.051 -7.30 ± 0.17 16.1 ± 1.0 
HA 104.76 ± 31.40 1.000 ± 0.000 -7.95 ± 0.56 14.0 ± 1.0 
200 
PBS 215.27 ± 1.75 0.012 ± 0.009 -35.23 ± 2.66 17.2 ± 0.5 
No Serum 210.83 ± 6.07 0.021 ± 0.021 -26.57 ± 1.29 15.0 ± 0.6 
FBS 288.90 ± 17.13 0.235 ± 0.011 -9.81 ± 0.39 15.2 ± 0.9 
PBF 185.73 ± 5.08 0.535 ± 0.037 -7.41 ± 0.15 15.1 ± 0.6 
HA 182.60 ± 9.00 0.606 ± 0.024 -9.34 ± 0.79 13.4 ± 0.5 
500 
PBS 568.87 ± 4.90 0.103 ± 0.015 -33.83 ± 1.59 16.6 ± 0.5 
No Serum 556.33 ± 25.72 0.267 ± 0.044 -22.57 ± 3.10 15.1 ± 0.6 
FBS 614.20 ± 110.16 0.629 ± 0.088 -8.92 ± 053 15.4 ± 0.8 
PBF 710.07 ± 39.22 0.659 ± 0.047 - 7.45 ± 0.15 15.3 ± 0.6 
HA 670.83 ± 43.32 0.615 ± 0.135 -10.72 ± 1.12 13.4 ± 0.8 
 
As can be depicted from Table 3, NPs showed similar sizes to their nominal 
sizes and high levels of monodispersity (PDI < 0.3), when measured in PBS buffer, as 
it would be expected, indicating there’s a low heterogeneity of particle sizes in the 
solution.134   The differences between the nominal size and the measured size are 
mainly due to the DLS technique not being very sensitive to such small particles.38 
Some levels of aggregation were to be expected when NPs were dispersed in 
medium supplemented with different sera, since in those conditions NPs have a 
tendency to aggregate, leading to an increase in size and to PDI values > 0.3, 
indicating a higher heterogeneity of particle sizes dispersed.134 This was also due to the 
fact that the DLS technique used quantifies size distributions and its results are 
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influenced by NPs aggregation.38 This was verified in most NPs dispersed in medium 
supplemented with different sera, where the hydrodynamic diameter was superior to 
the nominal size, and was especially true in all NPs sizes dispersed in medium 
supplemented with FBS and in all 500 nm NPs dispersed in the medium supplemented 
with different sera (Table 3).  
A few exceptions was also observed, namely 20 nm NPs dispersed in CM, 
supplemented in HA, presented an hydrodynamic diameter very close to 20 nm, but 
with a PDI value of 0.757.134 And 200 nm NPs dispersed in medium supplemented with 
PBF and HA, also had a smaller hydrodynamic radius than expected, combined with a 
PDI value bigger than 03. Perhaps this can be due to the presence of lower levels of 
serum protein aggregates, which will influence the size measurements.  
It is worth mentioning that, according to literature, the formation of a protein 
corona does not usually alter the hydrodynamic diameter significantly, when comparing 
it to a bare nanoparticle (without a protein corona). The thickness of the protein corona 
is usually around 4 to 10 nm. Hence, the more significant differences of hydrodynamic 
diameter observed are probably due to aggregation and the formation of several NP-
protein multimers.99 For instance, Nienhaus et al. determined the thickness of a 
monolayer of human serum albumin on 10-20 nm polymer coated FePt and CdSe/ZnS 
nanoparticles to be of 3.3 nm, indicating that the hydrodynamic diameter changes 
probably are most likely a results of the formation of multimers and not solely due to 
the presence of protein corona.135 
Zeta potential measurements indicated the superficial charge of NPs and were 
also used to indicate the stability behavior of a colloid dispersion: the more positive it 
was, the more stable the colloid dispersion was. Zeta potential measurements (Table 
3) showed that NPs were negatively charged, after incubation in PBS buffer or medium 
without serum, which was expected since they are carboxylate modified. They had 
similar values since all used NPs, regardless of size, have the same composition and 
modification. The surface charge of the particles dispersed in PBS were more negative 
(approximately -35 mV) than the particles dispersed in SFM (approximately -23 mV). 
This was probably due to the presence L-glutamine in the SFM (the RPMI medium), 
with amine positive groups, which helped stabilize the NPs more than the cations 
present in PBS buffer. The lower negative charges in serum supplemented with the 
different sera can be explained by the protein adsorption on the NPs surface (Table 3). 
Dawson et al. suggested that this is due to a different dispersion stabilization 
mechanism (involving charge and steric hindrance) from the typical one for bare NPs. 
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This stabilization is likely conferred by specific protein layer characteristics, where the 
entire protein complex surrounding the NP is colloidal stable, despite the crowded 
environment.99  
The dielectric constant (ε, also called relative permittivity) measurements served 
as controls and were approximately 15 μm.cm/V.s for the NPs dispersed in SFM and in 
medium supplemented with the different sera, and 16 μm.cm/V.s in PBS (Table 3). The 
minor differences found in these measurements, namely between the medium 
supplemented with different sera, were probably due to each serum having a distinct 
composition, which altered the dielectric constant of the solution.  
 
4.3. Assessment of NPs Internalization by Flow Cytometry 
Flow cytometry was used to measure average cell fluorescence intensity after 
incubation with 20 µg/mL of fluorescently labeled NPs for 24h. Since each nanoparticle 
size used has a respective mean fluorescence intensity, results will be presented in 
terms of fold increase (fluorescence intensity of cell incubated with NPs/untreated 
cells), comparing only between serum conditions. Furthermore, in order to verify that all 
fluorescence measurements were due to nanoparticles internalized in the respective 
cells, the efficiency of the washes was verified and the results are shown in Figs. 3 and 
S1, for GP202 and MKN28 (CD44v6 -) cell lines.  
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Figure 3 - Fluorescence intensity results of the 40 NP solution used to incubate cells and supplemented with different 
sera, before incubation and after three washes. (A) MKN28 (CD44v6c -) cells, (B) GP202 cells. 
The efficacy of the three washes was thus demonstrated since the fluorescence 
intensity values remaining in the third wash were very low, comparing to the intensity 
levels of the initial NP solution. 
Afterwards, the influence of NP size and the respective protein corona (after 
pre-incubation in the different sera) on the NPs uptake (during 24h), across various cell 
lines, were studied and results are shown in Fig. 4. Our main interest here was to 
compare the results obtained in the ’no serum’ condition with the ‘PBF’ condition. Since 
PBF serum is a human rich type serum, currently being used by Orthosera in their 
medical experiments, and prepared from blood samples of the same donor. While FBS 
is pooled from different animal donors and there wasn’t an interest in applying a 
statistical treatment to these results, due to the possible inconsistences between FBS 
batches. And, in the ‘HA’ it simply served as control, since it was a very simple serum. 
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Figure 4 - Influence of NP size and protein corona on the NPs uptake (during 24h) across various cell lines. (A) AGS cell 
line; (B) GP202 cell line; (C) HeLa cell line; (D) MKN28 cell line (CD44v6 -); (E) MKN28 cell line (CD44v6 +); (F) hMSC 
cell line; (G) HEK293t cell line. Results are reported as fold increase ± S.D. of NPs uptake relative to cells that were not 
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exposed to NPs, averaged between two replicas of three independent experiments. * t < 0.05, compared with respective 
NPs size in the No Serum condition. 
 
 In terms of the influence of the different protein corona and NP size on cell 
uptake, results show a clearly distinct behavior especially when observing 20, 40 and 
500 nm NPs. For the 20 and 40 nm NPs, results show that protein adsorption on their 
surface decreased their subsequent uptake by the different cells quite significantly, 
clearly observed when comparing conditions without serum and/or ‘FBS’ and ‘PBF’, as 
was reported in other works concerning the uptake of polystyrene nanoparticles.134, 136 
In fact, when nanoparticles were exposed in the absence of serum in the culture 
medium, significantly higher uptake was obtained. The reason behind this phenomenon 
was probably due to hydrophobic effects. When bare polystyrene nanoparticles were 
administrated to cells, their high surface hydrophobicity may  cause them to adhere to 
the already hydrophobic plasma membrane.137 On the other hand, in the presence of 
serum, adsorption of proteins probably diminished the non-specific hydrophobic binding 
of the nanoparticles to the cell surface, leading to a decrease of the surface 
hydrophobicity and a consequently lower, but more specific, uptake of the 
nanoparticles via cellular receptors.137, 138 
Surprisingly, opposite results were obtained when nanoparticles with 500 nm 
were used, where a clear inversion of behavior can be observed, especially when 
comparing ‘no serum’ and ‘PBF’ conditions. This phenomenon could be explained by 
the existence of a particular group of proteins (in a certain ratio) in the protein corona 
composition of these 500 nm NPs that were able to activate the cellular machinery in a 
different manner in this NP size, increasing their respective internalization. Other 
possible explanation could involve the conformation and orientation of the adsorbed 
proteins in the corona that may expose different and/or more recognizable domains 
which leads to a bigger NPs uptake.  
Results for MKN28 cell lines (Figs. 4D and E), expressing or not CD44v6, 
showed that the difference of uptake between “no serum” and “PBF” for 500m, verified 
previously, didn’t occur in this case; an increase in the uptake of 500 nm particles was 
not observed, when compared with the “no serum” condition. More experiments are 
required to explain this difference of behavior, although we hypothesized that it may be 
due to differences of proteomic profile between all the cell lines studied. Nevertheless, 
between MKN28 and MKN28 (CD44v6 +), they showed similar internalization profiles, 
although the latter has a slightly smaller fold increase across all conditions and NPs 
sizes. This could be due to the fact that MKN28 cells, expressing CD44v6, having an 
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increased cell-cell adhesion, which may be responsible for compromising the 
internalization of NPs. The presence/absence of CD44v6, didn’t impact the 
internalization of NPs, as it was expected. 
Also, the uptake of 500 nm NPs exhibiting a protein corona originated from FBS 
and HA, both seemed higher than the uptake of bare 500 nm NPs (‘no serum’ 
condition), like in the case of the HeLa or Hek293t (Figs. 4C and G, respectively), or 
lower, as in the case of GP202 (Fig. 4B). But, as it can be seen, AGS and hMSC do not 
follow this pattern (Figs. 4A and F).  
Overall, it seems that smaller NPs (20-200 nm), with a protein corona formed 
with PBF proteins, result in a lower uptake when compared to equally-sized NPs 
present in SFM. But, as the NPs become larger and reach 500 nm, after coating with 
proteins derived from PBF, their uptake was higher than their equivalents in the no 
serum condition, except for both MKN28 cell lines. 
In terms of fold increase, hMSC had the highest uptake of 20 and 40 nm 
particles, in SFM or CM supplemented with FBS, while in the PBF and HA conditions, 
the uptake was essentially even across cell lines (Figs. 5A and B). But for NP sizes 
larger than 40 nm, it can be noticed that the two cell lines that resulted in the highest 
uptake, across all conditions, were GP202 and hMSC. Also in Figs. 5 C, D and E, the 
tendency mentioned before can be clearly observed between the ‘no serum’ and ‘PBF’ 
conditions, across all cell lines. 
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Figure 5 - Influence of protein corona and cell-type specificity on the NPs uptake (during 24h) in terms of NP sizer 
across different cell lines. (A) 20 nm; (B) 40 nm; (C); 100 nm (D) 200 nm; (E) 500 nm. Results are reported as fold 
increase ± S.D. of NPs uptake relative to cells that were not exposed to NPs, averaged between two replicas of three 
independent experiments. * t < 0.05, compared with respective cell line for each No Serum condition. 
In general, when comparing NPs uptake by cancer cell lines and nonmalignant 
cell lines (like Hek293t and hMSC), no distinct pattern could be observed. A possible 
explanation for the higher uptake of NPs in hMSC and GP202 cell line might be due to 
an increased gene expression, but no literature was found concerning the matter at 
hand. 
Some research works were published, studying protein corona formation as the 
result of blood fraction exposure and how it plays a major part in the internalization of 
resulting NPs.136, 139-141 For example, Schöttler et al. reported distinct and major 
differences in the uptake of polystyrene NPs incubated in FBS, human serum, human 
citrate and heparin plasma. They found that heparin potentiated the uptake into 
macrophages, but they prevented internalization into HeLa cells, while human citrate 
seemed to had the most important results in the in vitro studies of NPs uptake.136 
 They also concluded the need to investigate the protein sources of the serums 
or plasma used to incubate the NPs, and to determine the composition of the hard 
protein corona, since there was a prominent difference not only between the human 
and bovine media, but also between serum and plasma (serum is depleted from 
coagulation factors, while plasma contains proteins from the coagulation system), and 
the anticoagulants used in the plasma generation.92, 136, 142 Although PBF production is 
anticoagulant-free, the composition of each serum should indeed be determined, in 
order to compare the obtained results to other works. 
0
20
40
60
80
100
120
140
160
No serum FBS PBF HA
fo
ld
 in
cr
ea
se
Sera
E - 500nm
AGS
GP202
Hela
MKN28
MKN28+
hMSC
HEK293t
* 
* * 
* 
* 
FCUP/ICBAS 
The role of adsorbed proteins in the internalization of polymeric nanoparticles 
30 
 
The kinetics of NPs uptake was also studied using the GP202 cell line (Fig. 6). 
The same conditions were kept and only the NPs with nominal sizes of 40 and 500 nm 
were used in these experiments. These two sizes were chosen since they were proven 
to be statistically relevant for all cell lines (except MKN28 cell lines), when comparing 
the fold increase changes, in the SFM and in the medium supplemented with PBF. 
 
 
Figure 6 - Time profile of 40 and 500 nm NPs uptake in GP202 cell line. The same conditions were used and the time 
points chosen for this experience were 30 min, 1, 3, 6 and 24h. Results are presented as fold increase levels of NPs 
uptake, with respect to control cells that were not exposed to NPs, averaged between 2 independent replicas of 1 
independent experiment. 
In Fig. 6A, for the first 60 min, the fold increase remained very low and stable 
(fold increase level of approximately 1.5). But, after the 60 min, the NPs uptake steadily 
increased until the 1440 min time point (24h). Even though the results presented in Fig. 
6 are from one single experiment, the fold increase levels at 24h demonstrate the same 
tendency of the results obtained in the previous experiments (Fig. 4B), with the same 
incubation period of 24h. The highest NPs uptake was observed using bare particles 
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(this value is lower than the correspondent one in Fig. 4B, which had a fold increase of 
27.08). The rest of the fold increase levels were similar to the ones obtained in Fig. 4B, 
when comparing the results of NPs of the same size, incubated in the same medium 
conditions. 
In Fig. 6B, for the first 60 min, the fold increased also remained stable and low, 
at an approximate level of 3. Then, after the 180 min time point, the fold increase in 
NPs uptake continued to grow bigger, among the different sera conditions. At 24h, the 
highest uptake happened with the 500 nm NPs with a PBF and FBS-originated protein 
corona, which had similar levels between them. This is different from our previous 
results, in Fig. 4B, where 500 nm NPs with a PBF-originated ‘corona’ were significantly 
more uptaken than the same-sized NPs with an FBS-originated ‘corona’. The uptake of 
500 nm particles in medium supplemented with HA was also similar to the uptake of 
same-sized NPs in SFM.  
Also in Fig. 6B, the uptake of 500 nm particles, incubated in SFM, presented a 
small peak at the 30 min time point, but since these fold increase levels were only 
averaged between two independent replicas of one independent experiment, this could 
be meaningless, since it will be necessary to repeat this experience, at least two more 
times. It will also be interesting to see if the other cell lines used in this work will 
present a similar uptake pattern and if they demonstrate the same tendency that was 
reported in the flow cytometry results. 
Cellular internalization was further characterized, for the first time, by Imaging 
flow cytometry, a recent technology that allows the fast imaging of a high quantity of 
cells in flow. It combines the speed and sensitivity for fluorescence intensity 
quantification of conventional flow cytometry with the morphological features 
discrimination of microscopy, for the specific location and distribution of signals within 
individual cells and in the whole cellular population.  
For these preliminary experiments, cell uptake studies were only performed with 
NPs with the nominal sizes of 40 and 500 nm, under the same serum conditions as 
before, and using the Hek293t, HeLa, GP202, MKN28 (CD44v6 -) and AGS cell lines. 
The internalization feature of the IDEAS software was used to obtain the results seen 
in Fig. 7, while more detailed information can be found on Table S4 and Fig. S3, the 
latter describing the process of using the internalization feature. Internalization score is 
defined as the ratio of the intensity inside the cell to the intensity of the entire cell. The 
higher the score, the greater the number of NP inside the cell. Therefore, it was 
important to define the inside (cytoplasm) and the membrane of the cell for this 
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measurement. For the calculus of the median value of the internalization score, only 
cells with an internalization score > 0 were considered (defined in Fig. S3D as 
Internalization positive). Cells with a negative internalization score have a greater NP 
intensity at the cellular membrane level, than compared with the intensity inside the 
cell, therefore they were excluded from the calculations.  
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Figure 7 - Influence of NP size and protein corona on the NPs uptake (during 24h) across various cell lines, as 
assessed by imaging flow cytometry. (A) Hek293t cell line; (B) HeLa cell line; (C) GP202 cell line; (D) AGS cell line; (E) 
MKN28 cell line. Results are reported as median value of the internalization score of NPs uptake taking in consideration 
the internalization feature of the IDEAS software  
 The preliminary results obtained through imaging flow cytometry, and 
comparing with those performed previously by flow cytometry, confirm the previous 
behavior observed for the 40 nm NPs, namely a lower internalization in the “PBF” 
condition, compared to the “No serum” condition. However, the increased uptake of 
500 nm particles in the same condition, was not verified, at least to the same level 
found by flow cytometry. In this later case, as shown in Fig. S4, the signal from NPs 
was shown to be saturated (throughout all serum conditions) and there were barely any 
differences in the internalization score of 500 nm particles among all cell lines (Fig. 7), 
indicating that additional experiments and new settings need to be optimized in order to 
better correlate both techniques. A possible way to decrease the obtained signal 
saturation, could pass through using a lower concentration of NPs in the incubation 
solution, or different instrument settings could be used to analyze the 40 and 500 nm 
NPs.  
According to the results presented in Fig. 7, the cell line with the biggest uptake 
of 40 and 500 nm NPs was the HeLa cells (except in the uptake of 40 nm NPs with a 
protein corona derived from PBF). This wasn’t expected, since the previous results 
(Fig. 4B and C) obtained through flow cytometry indicated that there was a more 
substantial NPs uptake in the GP202 cell line, when compared to the HeLa cell line. 
The reason for this could be due to the complexity and additional gating presented in 
the internalization score calculation, which needs to be optimized.  
 
Figure 8 - Comparison of the uptake of 40 nm NPs, in medium supplemented with PBF, in two AGS cells (left images) 
with the uptake of 500 nm NPs, in medium without serum, also in two AGS cells (right images).  
 
Other issues that require further optimization were detected when exploring 
imaging flow cytometry for the current purpose. The instrument settings used were the 
same for the analysis of all samples and they correspond to the lowest intensity power 
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possible (488 nm laser power: 10.00; 785 nm laser power: 11.00). But even with such 
low intensity, cells with a very high uptake of either sized NPs, had their signal 
saturated. Even 40 nm NPs, which possessed lower fluorescence than 500 nm NPs, 
had their signal saturated in cases of a very high uptake, as it can be seen in Fig. S4A, 
B and D. On the other hand, the 40 nm NPs, incubated in media supplemented in 
“PBF” serum, were difficult to be visualized, due to their lower uptake and the used 
settings (Figs. S4 C). Nonetheless, a smaller uptake of these particles was verified, 
when compared with same-sized particles incubated in SFM, which was one of the 
intended goals of these first experiences. It can also be noticed in Table S4 that, even 
though the equipment was set to acquire 10 000 cells, the cell count is not exactly 
10 000 cells. This is due to interruption in the flow when the equipment stops acquiring 
events, and some cells may be removed and neglected or taken into consideration, 
depending on their morphology. Also, more than half of the cells acquired are not used 
in the calculation of the median (Table S4 and explained in Fig. S3). Additional 
experiments will be needed to confirm the internalization score results obtained in 
imaging flow cytometry.  
Looking at the merged images of Fig. 8 and Fig. S3, the nanoparticles were 
clearly located throughout the cytoplasm, but to infer more information than that is very 
difficult. The Imagestream is also capable of analyzing more fluorophores and it is 
especially used for co-localization assays as well, through the use of the co-localization 
feature of the IDEAS software, and for counting NPs, through the spot count feature of 
the same software. Both features are able to significantly contribute to the quantity and 
location of NPs within a cell.143, 144 
It should be noted that most of the work consisted in in vitro experiments and 
using cell culture models. Such approach was selected because there is very little 
information about the effects/consequences of protein adsorption on nanoparticles in 
vivo. This is due to the complexity of the in vivo situation since, after intravenous 
injection of nanoparticles in a living organism, these will almost immediately form their 
respective protein coronas throughout the circulatory system, facing billions of moving 
cells and the large surface area of the vascular endothelial cells, making it very difficult 
a study similar to the present one.102 
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5. Conclusions and Perspectives 
In summary, the cell uptake profile of NPs is dependent of the NPs size, the 
proteins absorbed to the NP surface, and the type of cells studied, confirming the 
complexity of endocytosis of NPs by cells. More importantly, the data obtained in this 
work highlights that smaller NPs, when exhibiting a PBF-originated protein corona, are 
less uptaken by cells, when compared to equally-sized NPs in SFM. On the contrary, 
larger NPs, that present the PBF-originated corona, resulted in an increasingly high 
uptake by cells, when compared to same-sized NPs in the SFM. Understanding the 
reason for this change in the uptake, could lead to a better understanding of 
endocytosis and, consequently, to possibly new drug delivery techniques in 
nanomedicine. 
Future work includes the continuation of the NPs uptake experiments, 
expanding to other cell lines, like the SW892 synovial fibroblast cell line, to see if the 
tendency demonstrated by the PBF condition remains. It would also be interesting to 
test how NPs uptake would play out in different types of primary cells.  
The detailed study of the PBF serum and the composition of the protein corona, 
through western blots and proteomics are also extremely important to explain the 
differences observed in the protein coronas formed. It can also lead to potential new 
uses for the PBF serum. Time profiles of the NPs uptake experiments should be 
repeated in all the cell lines.  
Finally, the use of imaging flow cytometry to characterize NPs internalization by 
cells should be further explored and optimized, especially to allow detection of NP 
localization. The cell lines tested here and the differently sized NPs should also be 
included in forthcoming studies. The spot count and the co-localization features of the 
Imagestream constitute powerful tools that should be further explored, to determine the 
final localization of the NPs within the cell. 
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Table S1- Albumin standards and respective RFU values. Average is obtained from two replicas. The blank value is 
subtracted from the average value of each standard. 
[Protein] 
µg/ml 
Average / 
RFU 
Average - Blank / 
RFU 
2000 0.973 0.898 
1500 0.756 0.681 
1000 0.503 0.428 
750 0.398 0.323 
500 0.285 0.209 
250 0.172 0.096 
125 0.116 0.040 
Blank 0.076   
 
 
Figure S1 - Albumin calibration curve plotted with the results presented in Table 3. 
 
Table S2- Measurements of fluorescence of FBS, PBF and HA serum, with a dilution factor of 1:10, and respective total 
protein content. This was a possible example on how to proceed with the quantification of protein content. 
Serum Replica 1 / RFU 
Replica 2 
/ RFU 
Replica 3 
/ RFU 
Average 
/ RFU 
Average-
blank / RFU Total protein (µg/ml) 
FBS 3.697 3.735 3.693 3.708 3.633 7156.27 
PBF 3.351 3.350 3.376 3.359 3.284 6457.60 
HA 1.874 1.878 1.680 1.811 1.735 3360.93 
 
Knowing the total protein content of each serum, it was then possible to 
determine the % PBF and % HA providing the same protein content as 10% of FBS, 
through the following formula: 
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100%×ܶ݋ݐ݈ܽ ݌ݎ݋ݐ݁݅݊ ܿ݋݊ݐ݁݊ݐ (ܨܤܵ)
ܶ݋ݐ݈ܽ ݌ݎ݋ݐ݁݅݊ ܿ݋݊ݐ݁݊ݐ (ܲܤܨ ݋ݎ ܪܣ)
= % ݋݂ ܲܤܨ ݋ݎ % ݋݂ ܪܣ ݊݁݁݀݁݀ 
⟺
0.10 ×7156.27
6457.60
= 11.1 % 
 
Table S3 - % values of serum in CM, obtained in this example with the results of Table S 2. 
Serum % in CM 
FBS 10.0 
PBF 11.1 
HA 21.3 
 
 Three different solutions were prepared and then used to incubate the NPs 
before adding the mixture to the cells. It is also worth mentioning that every time a new 
stock of serum was used, the respective protein content was determined in order to 
assure maximum reproducibility. 
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Figure S2 – Fluorescence intensity results of the 20, 100, 200 and 500 NP solution used to incubate cells and 
supplemented with different sera, before incubation and after three washes. (A-D) GP202 cells. (A) 20 NP solution, (B) 
100 NP solution, (C) 200 NP solution, and (D) 500 NP solution. (E-H) MKN28 (CD44v6c -) cells, (E) 20 NP solution, (F) 
100 NP solution, (G) 200 NP solution, and (H) 500 NP solution. 
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Table S4- Statistical report obtained in the analysis of the imaging flow cytometry results, in the IDEAS software. 
Cell 
Line Condition 
NP 
Size 
Cell 
Count 
Cell # used in 
Median 
calculation 
% of non-usable 
cells Median 
Hek293t 
No Serum 
40 nm 9626 1963 79.6 2.722 
500 nm 9670 2303 76.2 3.551 
FBS 
40 nm 10160 4221 58.5 1.966 
500 nm 9552 3288 65.6 3.374 
PBF 
40 nm 9659 2889 70.1 1.201 
500 nm 9578 2914 69.6 3.034 
HA 
40 nm 9747 2800 71.3 2.068 
500 nm 9711 2626 73.0 3.255 
HeLa 
No Serum 
40 nm 9762 3769 61.4 3.84 
500 nm 6834 3501 48.8 4.375 
FBS 
40 nm 9648 3284 66.0 2.97 
500 nm 9668 3083 68.1 4.973 
PBF 
40 nm 9636 3168 67.1 1.318 
500 nm 9817 3202 67.4 4.817 
HA 
40 nm 9714 3817 60.7 3.478 
500 nm 9698 3327 65.7 4.604 
GP202 
No Serum 
40 nm 9657 4990 48.3 2.588 
500 nm 9751 4833 50.4 2.622 
FBS 
40 nm 9159 3501 61.8 2.519 
500 nm 9005 3781 58.0 2.996 
PBF 
40 nm 9583 4339 54.7 1.855 
500 nm 9901 4604 53.5 3.336 
HA 
40 nm 9855 4331 56.1 2.321 
500 nm 9936 4369 56.0 2.626 
AGS 
No Serum 
40 nm 9617 4186 56.5 3 
500 nm 10059 4580 54.5 3.779 
FBS 
40 nm 9780 4134 57.7 1.54 
500 nm 9850 3389 65.6 3.542 
PBF 
40 nm 9858 3252 67.0 0.9137 
500 nm 9809 3457 64.8 3.544 
HA 
40 nm 9732 3183 67.3 2.022 
500 nm 9858 3118 68.4 3.39 
MKN28 
No Serum 
40 nm 9658 4662 51.7 1.831 
500 nm 6394 1019 84.1 1.969 
FBS 
40 nm 9471 4256 55.1 1.043 
500 nm 9465 2858 69.8 2.398 
PBF 
40 nm 7972 2278 71.4 0.4874 
500 nm 5983 423 92.9 1.395 
HA 
40 nm 9717 4501 53.7 1.309 
500 nm 8211 1707 79.2 0.7611 
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Figure S3 - Schematic exemplifying the usage of the internalization feature of Imagestream, in the uptake of 40 nm NPs, 
in serum free medium, by MKN28 cells. (A) Selection of focused cells area in the initial histogram. (B) Gating of the 
single cells, separating them from debris and double cells. (C) Gating of MKN28 cells positive for NPs, leaving the 
negative ones out of the gate. (D) Internalization score histogram, where the positions of the three different cells can be 
seen, with different scores of internalization. The work done on this sample was then used as the template for the 
remaining analysis of the rest of the samples 
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Figure S 4 - Comparison of the uptake of 40 nm NPs (left images) with the uptake of 500 nm NPs (right images), in HeLa 
cell line. (A) Uptake of NPs incubated in SFM. (B) Uptake of NPs incubated in media supplemented with FBS. (C) Uptake of 
NPs incubated in media supplemented with PBF. (D) Uptake of NPs incubated in media supplemented with HA. 
